# Advanced Enzyme Technologies

印度领先酶制剂生物技术公司（1989年创立，BSE: 540025）——400+种酶产品，覆盖制药、食品、动物营养和农业；FY26营收₹7.806亿（同比+16.5%）；高利润率专业细分市场，出口导向。

Source: https://cn.bioecon.ru/companies/advanced-enzyme-technologies/
Updated: 2026-06-19

- 国家: India
- 营收: ₹780.6Cr (~$93M)
- 员工: ~800 emp

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 产能 | 500立方米发酵产能 | https://www.advancedenzymes.com/wp-content/uploads/2026/05/IntimationEP-1.pdf, https://www.advancedenzymes.com/wp-content/uploads/2026/08/IntimationIP.pdf |
| 认证 | 通过ISO/IEC 27001:2022认证，供应商亦通过ISO认证 | https://www.advancedenzymes.com/wp-content/uploads/2026/07/Business-Responsibility-and-Sustainability-Report-FY26.pdf, https://www.advancedenzymes.com/wp-content/uploads/2026/08/IntimationIP.pdf, https://www.indiainfoline.com/company/advanced-enzyme-technologies-ltd/reports/directors-report |
| 监管批准 | 向EFSA提交17份食品酶档案（其中13份获得积极意见），10份GRAS档案经美国FDA评估 | https://www.advancedenzymes.com/wp-content/uploads/2026/08/IntimationIP.pdf, https://www.icra.in/Rating/GetRationalReportFilePdf?id=140898 |
| 生产基地 | 共9个生产单元（印度8个、美国1个） | https://www.advancedenzymes.com/wp-content/uploads/2026/05/IntimationEP-1.pdf, https://www.advancedenzymes.com/wp-content/uploads/2026/08/IntimationIP.pdf |
| 员工人数 | 截至2026年3月31日共762人（400名职员及362名工人） | https://scanx.trade/stock-market-news/companies/advanced-enzyme-technologies-reports-exports-at-33-58-in-fy26/45060093, https://www.advancedenzymes.com/wp-content/uploads/2026/07/Business-Responsibility-and-Sustainability-Report-FY26.pdf |
| 营收 | 印度卢比74.58亿（FY26合并收入） | https://www.indiainfoline.com/company/advanced-enzyme-technologies-ltd/reports/directors-report |

独立来源: advancedenzymes.com, icra.in, indiainfoline.com, scanx.trade

## 技术

- [工业酶与生物催化](https://cn.bioecon.ru/technology/industrial-enzymes-biocatalysis/)
- [石油化工中的生物催化](https://cn.bioecon.ru/technology/biocatalysis-petrochemistry/)
- [酶法质构与风味改良](https://cn.bioecon.ru/technology/enzymatic-texture-flavor-modification/)